Cipla launches ‘ViraGen’ a polymerase chain reaction (Covid-19 RT-PCR) test Kumar Jeetendra | May 20, 2021 Mumbai, India; May 20 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd. ViraGen is Cipla’s third offering in the Covid-19 testing segment. Cipla already has partnerships …
Glenmark Pharma gets USFDA gesture for Icatibant Injection Kumar Jeetendra | May 25, 2021 Drug major Glenmark Pharma on Monday said it has received final approval from the US health regulator for Icatibant Injection, indicated for the treatment of acute attacks of hereditary angioedema (HAE). Hereditary angioedema (HAE) is a disorder that results in recurrent attacks of severe swelling. The approved product is a generic version of Firazyr Injection …
India has held talks with Pfizer, Johnson & Johnson, Moderna for COVID-19 vaccines Kumar Jeetendra | May 27, 2021 India has held several discussions with COVID-19 vaccine manufacturers Pfizer, Moderna and J&J, but there are no applications for approval pending with its regulators, the government said on Thursday. “Government offered all assistance to have them supply and or manufacture their vaccines in India,” the government said in a statement. “No application of any foreign …
Glenmark Pharma gets last gesture from USFDA for Theophylline ER tablets Kumar Jeetendra | June 4, 2021 Glenmark Pharma on Friday said it has received final approval from the US health regulator for Theophylline extended-release (ER) tablets. Theophylline extended-release tablets are used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. In a regulatory filing Glenmark Pharmaceuticals said it has …
Brazil probes Health Ministry arrangement to purchase Covaxin vaccine Kumar Jeetendra | June 23, 2021 Brazil’s federal prosecutor’s office is investigating possible irregularities in a Health Ministry contract to purchase 20 million doses of the Covaxin vaccine manufactured by Indian laboratory Bharat Biotech. The agreement signed in February commits the ministry to pay USD 320 million – at a cost of USD 15 per vaccine dose – to Precisa Medicamentos, …
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19 Kumar Jeetendra | June 29, 2021 India. June 29, 2021 – Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”), Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to as “Dr. Reddy’s”), Emcure Pharmaceuticals Limited (hereafter referred to as “Emcure”), Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, …
Optima Laboratory Resource Management System V2021.1 Software Release Announcement Kumar Jeetendra | July 2, 2021 Madrid, Spain – 01 July 2021 – – We are delighted to announce the new Optima Laboratory Resource Management System – LRMS version 2021.1. released by July 1st, 2021. It is a major milestone incorporating a sophisticated engine that automates the complex scheduling process of the laboratory resources. Optima’s algorithm combines all information collected in …
Alembic Pharma gets last approval from USFDA for OCD treatment drug Kumar Jeetendra | August 5, 2021 New Delhi, Aug 5 (PTI) Drug firm Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for Clomipramine Hydrochloride capsules, used for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The company has received final approval from the US Food and Drug Administration (USFDA) for …
Aurobindo Pharma gets USFDA gesture for malignancy treatment injection Kumar Jeetendra | August 27, 2021 New Delhi, Aug 27 (PTI) Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US health regulator for Cyclophosphamide injection, used in the treatment of several types of cancer. The company”s subsidiary “Eugia Pharma Specialities Ltd has received a 505(b)(2) NDA approval from the US Food & …
India considers continuing vaccine export soon,focus around Africa, says source Kumar Jeetendra | September 15, 2021 India is considering resuming exports of COVID-19 vaccines soon, mainly to Africa, as it has partly immunised a majority of its adults and supplies have surged, a source with knowledge of the matter told Reuters. India, the world’s biggest maker of vaccines overall, stopped vaccine exports in April to focus on inoculating its own population …
Reducing Microbial Contamination Risk in Pharmaceutical Manufacturing Kumar Jeetendra | November 24, 2021 Event Date : 15th Dec at 3:30 PM IST LIVE WEBINAR Reducing Microbial Contamination Risk in Pharmaceutical Manufacturing LIVE WEBINAR / 15th Dec at 3:30 PM IST / Host Kacey Pouliot REGISTER NOW! WEBINAR BY KACEY POULIOT ON 15th Dec at 3:30 PM IST EVENT AGENDA With regulations only becoming more stringent and new biologics …
Alembic announces seed round investment in RIGImmune, Inc. Kumar Jeetendra | December 10, 2021 10th December, 2021, Mumbai: Alembic Pharmaceuticals Limited (Alembic) has announced today that it has made a strategic investment in RIGImmune Inc., a biopharmaceutical research company co-founded by two prominent Yale University professors. RIGImmune Inc. was founded by Dr. Anna Pyle and Dr. Akiko Iwasaki. Dr. Pyle is a Professor of Molecular, Cellular and Developmental Biology …
